n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride in 10 studies
| Studies (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Trials (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Recent Studies (post-2010) (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Studies (1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride) | Trials (1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride) | Recent Studies (post-2010) (1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride) |
|---|---|---|---|---|---|
| 98 | 0 | 29 | 113 | 2 | 41 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, T; Matsuno, K; Mita, S; Tanaka, MK | 1 |
| Matsuno, K; Mita, S; Nakazawa, M | 1 |
| Kameyama, T; Maeda, H; Matsuno, K; Nanya, Y; Ukai, M | 1 |
| Ashby, CR; Matsuno, K; Minabe, Y | 1 |
| Nabeshima, T; Nakata, Y; Sasa, M; Yamada, K; Zou, LB | 1 |
| Fujita, Y; Hashimoto, K; Iyo, M | 1 |
| Atta, MS; Hirata, Y; Kiuchi, K; Mahmoud, S; Oh-hashi, K; Yamamoto, H | 1 |
| Fukunaga, K; Han, F; Ishida, K; Kobayashi, T; Matsumoto, T; Nemoto, S; Tagashira, H; Taguchi, K; Zhang, C | 1 |
| Aki, M; Junpei, O; Kazumi, Y; Masato, H; Mika, F; Teruo, H; Tomohisa, M; Tsutomu, S | 1 |
| Li, D; Liu, XY; Ma, XY; Wei, XL; Xiang, Y; Yan, HT; Yao, YH; Zhang, SZ | 1 |
10 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride
| Article | Year |
|---|---|
Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test.
Topics: Animals; Anisoles; Cinnamates; Cyclopropanes; Guanidines; Male; Mice; Mice, Inbred Strains; Motor Activity; Pentazocine; Piperazines; Propylamines; Receptors, sigma; Stress, Physiological | 1996 |
Activation of sigma1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures.
Topics: Animals; Anisoles; Cells, Cultured; Ligands; Neurons; Nootropic Agents; Pentazocine; Piperazines; Propylamines; Rats; Rats, Wistar; Receptors, sigma | 1998 |
Beneficial effects of acute and repeated administrations of sigma receptor agonists on behavioral despair in mice exposed to tail suspension.
Topics: Animals; Anisoles; Antidepressive Agents; Body Weight; Desipramine; Drug Interactions; Fluoxetine; Hindlimb Suspension; Male; Mice; Motor Activity; Narcotics; Nootropic Agents; Pentazocine; Piperazines; Propylamines; Receptors, sigma | 1998 |
Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study.
Topics: Animals; Anisoles; Cell Count; Dopamine; Drug Administration Schedule; Electrophysiology; Male; Membrane Potentials; Mesencephalon; Microelectrodes; Neurons; Nootropic Agents; Piperazines; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Substantia Nigra; Ventral Tegmental Area | 1999 |
Effects of sigma(1) receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats.
Topics: Animals; Anisoles; Antipsychotic Agents; Dehydroepiandrosterone Sulfate; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Maze Learning; Memory; Nootropic Agents; Piperazines; Pregnenolone; Progesterone; Propylamines; Psychomotor Performance; Rats; Rats, Wistar; Receptors, sigma; Steroids; Time Factors | 2000 |
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.
Topics: Analysis of Variance; Animals; Anisoles; Antipsychotic Agents; Behavior, Animal; Choice Behavior; Cognition Disorders; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Fluvoxamine; Mice; Mice, Inbred ICR; Motor Activity; Nootropic Agents; Phencyclidine; Piperazines; Propylamines; Receptors, sigma; Retention, Psychology; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor | 2007 |
Chloroquine inhibits glutamate-induced death of a neuronal cell line by reducing reactive oxygen species through sigma-1 receptor.
Topics: Animals; Anisoles; Cell Death; Cell Line, Transformed; Cell Survival; Chloroquine; Dose-Response Relationship, Drug; Drug Interactions; Ethylenediamines; Gangliosides; Glutamic Acid; Glutathione; Mice; Neurons; Neuroprotective Agents; Oxidative Stress; Piperazines; Propylamines; Reactive Oxygen Species; Receptors, sigma; Sigma-1 Receptor; Time Factors | 2011 |
Vascular endothelial σ1-receptor stimulation with SA4503 rescues aortic relaxation via Akt/eNOS signaling in ovariectomized rats with aortic banding.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Anisoles; Antipsychotic Agents; Aorta, Abdominal; Aortic Diseases; Cyclic GMP; Endothelin-1; Endothelium, Vascular; Female; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type III; Nootropic Agents; Ovariectomy; Phenylephrine; Phosphorylation; Piperazines; Propylamines; Proto-Oncogene Proteins c-akt; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Vasodilation | 2013 |
Possible involvement of the Sigma-1 receptor chaperone in chemotherapeutic-induced neuropathic pain.
Topics: Animals; Anisoles; Antineoplastic Agents; Blotting, Western; CHO Cells; Cricetulus; Hyperalgesia; Male; Microscopy, Fluorescence; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Piperazines; Propylamines; Rats, Sprague-Dawley; Receptors, sigma; Sensory System Agents; Sigma-1 Receptor; Spinal Cord; Touch; Transfection | 2015 |
Sigma-1 receptor agonist increases axon outgrowth of hippocampal neurons via voltage-gated calcium ions channels.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anisoles; Axons; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Dose-Response Relationship, Drug; Female; Hippocampus; Male; Membrane Potentials; Morpholines; Neurites; Neurons; Nootropic Agents; Patch-Clamp Techniques; Piperazines; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sigma-1 Receptor; Time Factors; Tubulin | 2017 |